Fabrys disease
Immune checkpoint inhibitors (PD-1, PD-L1, CTLA-4) Mechanisms and clinical manifestations Immune checkpoint inhibitors (ICIs) are complementary therapies of cancers and are considered to be the most innovative and promising drugs in cancer treatment, including programmed death 1(PD-1), programmed cell death-Ligand 1(PD-L1), and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) monoclonal antibodies against these suppressor receptors expressed by tumor cells, T cells, and other immune cells
Recently, a rare ApoE variant, ApoE3-Ch, was found to protect against both early-onset AD and in late onset AD (Nelson et al., 2023)
doi: 10.1016/j.mam.2004.06.006 13
Aus 4 Grnden ist Glutathion plus Ko-Faktoren optimal Glutathion, kurz GSH, ist eine multifunktionelle und natrlich vorkommende Substanz, die antioxidativ wirkt, entgiftet und das Immunsystem untersttzt